TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanism

Source
Gut : the journal of the British Society for Gastroenterology - ISSN 0017-5749- (2024) p. 1-11
Author(s)
    Armando Andres Roca Suarez, Marie-Laure Plissonnier, Xavier Grand, Maud Michelet, Guillaume Giraud, Maria Saez-Palma, Anaëlle Dubois, Sarah Heintz, Audrey Diederichs, Nicolaas Van Renne, Thomas Vanwolleghem, Stephane Daffis, Li Li, Nikita Kolhatkar, Yao-Chun Hsu, Jeffrey J. Wallin, Audrey H Lau, Simon P. Fletcher, Michel Rivoire, Massimo Levrero, Barbara Testoni, Fabien Zoulim